Effectiveness of low-level laser therapy on temporomandibular disorders. A systematic review of randomized clinical trials
Abstract
• Low-level laser therapy (LLLT) effectively reduces pain in patients with temporomandibular disorders (TMD), demonstrating a 60–70 % decrease in VAS pain scores. • Significant improvement in vertical aperture (VA) was observed, with an average increase of 10–20 %, especially with wavelengths between 810 and 940 nm. • LLLT showed superior outcomes compared to conventional treatments like occlusal splints, NSAIDs, and TENS therapy, particularly for myogenic TMD. • Treatment protocols involving more than four weeks provided longer-lasting pain relief and functional improvements. • LLLT demonstrated a high safety profile with minimal adverse effects, supporting its use as a non-invasive therapeutic option. This study aimed to systematically evaluate the efficacy of LLLT in the management of TMD, focusing on its impact on pain reduction and functional improvement. Additionally, this review sought to identify the most effective laser parameters (wavelength, energy density, and duration of therapy) and compare LLLT outcomes with conventional treatment modalities. A comprehensive search was conducted across PubMed, Scopus, Web of Science, and EBSCO databases until December 2024. Randomized controlled trials (RCTs) that evaluated LLLT's effects on pain (via Visual Analog Scale) and vertical aperture (VA) were included. The risk of bias was assessed using Cochrane's RoB 2 tool. This systematic review analyzed 44 randomized clinical trials (RCTs) with 1,816 participants, confirming…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,816 participants or records.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.